Literature DB >> 7649531

Geographic and ethnic distributions of the more frequent cystic fibrosis mutations in Europe show that a founder effect is apparent for several mutant alleles.

G Lucotte1, S Hazout.   

Abstract

Examination of the European geographic patterns of the 10 relatively most frequent cystic fibrosis mutations, other than the DF508 one, shows that a founder effect is apparent for a number of them. The most evident examples are for the W1282X mutation in Jews, with a probable Asian origin, and the G551D and R117H mutations in Celts. Geographic distributions indicate that the main focus of the 621 + 1 G-->T and DI507 mutations is probably located in Wales. Also, the R1162X mutation probably originates from a circumscribed north Italian region. The N1303K mutation has a wide range in Europe with a clear preponderance in southern countries. Even the relatively common G542X and 1717.1 G-->A mutations have a local preponderance in Spain and Sicily and in northern Italy, respectively. Likelihood estimates for recurrent mutation and identity by descent strongly support the hypothesis of recurrence for the (mainly German) mutation R553X.

Entities:  

Mesh:

Year:  1995        PMID: 7649531

Source DB:  PubMed          Journal:  Hum Biol        ISSN: 0018-7143            Impact factor:   0.553


  5 in total

1.  Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial.

Authors:  Richard B Moss; Patrick A Flume; J Stuart Elborn; Jon Cooke; Steven M Rowe; Susanna A McColley; Ronald C Rubenstein; Mark Higgins
Journal:  Lancet Respir Med       Date:  2015-06-09       Impact factor: 30.700

2.  Cystic fibrosis carriership and tuberculosis: hints toward an evolutionary selective advantage based on data from the Brazilian territory.

Authors:  Lander Bosch; Barbara Bosch; Kris De Boeck; Tim Nawrot; Isabelle Meyts; Dominique Vanneste; Cleonice Alexandre Le Bourlegat; Julio Croda; Luiz Vicente Ribeiro Ferreira da Silva Filho
Journal:  BMC Infect Dis       Date:  2017-05-12       Impact factor: 3.090

3.  Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis Infections.

Authors:  Edward F McKone; Pradeep K Singh; Samantha L Durfey; Sudhakar Pipavath; Anna Li; Anh T Vo; Anina Ratjen; Suzanne Carter; Sarah J Morgan; Matthew C Radey; Brenda Grogan; Stephen J Salipante; Michael J Welsh; David A Stoltz; Christopher H Goss
Journal:  mBio       Date:  2021-12-14       Impact factor: 7.867

4.  Ethnic Differences in the Frequency of CFTR Gene Mutations in Populations of the European and North Caucasian Part of the Russian Federation.

Authors:  Nika Petrova; Natalia Balinova; Andrey Marakhonov; Tatyana Vasilyeva; Nataliya Kashirskaya; Varvara Galkina; Evgeniy Ginter; Sergey Kutsev; Rena Zinchenko
Journal:  Front Genet       Date:  2021-06-16       Impact factor: 4.599

5.  BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1.

Authors:  J M Lancaster; M E Carney; J Gray; J Myring; C Gumbs; J Sampson; D Wheeler; E France; R Wiseman; P Harper; P A Futreal
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.